Even with long-term evidence of the superiority of intraperitoneal (IP) over intravenous (IV) chemotherapy for advanced ovarian cancer, controversy lingers.
Medscape Medical News …read more
Even with long-term evidence of the superiority of intraperitoneal (IP) over intravenous (IV) chemotherapy for advanced ovarian cancer, controversy lingers.
Medscape Medical News …read more
Comments are closed.
Nice posts! 🙂
___
Sanny
Look my site is good
___
http://davesdevotional.org
Look my site is good
___
http://afcmarseille.com